quinazolines has been researched along with Tauopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chiasseu, M; Chyung, A; Fesharaki-Zadeh, A; Luo, A; Nies, SH; Smith, LM; Strittmatter, SM; Takahashi, H; Tang, SJ | 1 |
| Chou, CH; Yang, CR | 1 |
| Ballatore, C; Brunden, KR; Cornec, AS; James, MJ; Koivula, P; Lee, VM; Oukoloff, K; Smith, AB; Trojanowski, JQ; Yao, Y; Zhang, B | 1 |
3 other study(ies) available for quinazolines and Tauopathies
| Article | Year |
|---|---|
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
Topics: Aged, 80 and over; Animals; Benzodioxoles; Brain Concussion; Enzyme Inhibitors; Humans; Male; Memory Disorders; Mice; Mice, Transgenic; Protein Aggregates; Protein Aggregation, Pathological; Proto-Oncogene Proteins c-fyn; Quinazolines; Synapses; tau Proteins; Tauopathies | 2020 |
Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.
Topics: Alzheimer Disease; Animals; Apoptosis; Brain; Cell Line; Cognition; Cognition Disorders; Disease Models, Animal; Humans; Male; Maze Learning; Mice; Mice, Inbred ICR; Neurodegenerative Diseases; Neurons; Neuroprotection; Neuroprotective Agents; Okadaic Acid; Phosphorylation; Quinazolines; Spatial Memory; tau Proteins; Tauopathies | 2021 |
A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Topics: Alzheimer Disease; Animals; Axonal Transport; Axons; Brain; Disease Models, Animal; Humans; Mice; Microtubules; Neurons; Quinazolines; tau Proteins; Tauopathies; Triazoles | 2018 |